Today: 24 March 2026
Subscribe
Browse Category

NASDAQ:QNCX 10 February 2026 - 11 February 2026

Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive

Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive

Quince Therapeutics shares jumped about 48% to 78 cents in premarket trading Wednesday after the company hired LifeSci Capital to explore strategic alternatives and liability restructuring. The move follows a failed late-stage drug trial and the resignation of five board directors. The stock surged from 13 cents Monday to 52.8 cents Tuesday on heavy volume. Investors await further disclosures or a timeline for next steps.
11 February 2026
·
Quince Therapeutics (QNCX) stock slides before the bell after LifeSci Capital deal review move

Quince Therapeutics (QNCX) stock slides before the bell after LifeSci Capital deal review move

Quince Therapeutics shares dropped 6.6% to $0.13 in premarket trading after the company hired LifeSci Capital to advise on strategic alternatives and liability restructuring. The move follows a failed Phase 3 trial in late January and the resignation of five directors. Quince said it will not provide further updates unless its board approves a specific action.
10 February 2026
·

Stock Market Today

  • Top TSX Stocks to Invest $1,000 in Now: Suncor Energy and Canadian National Railway
    March 23, 2026, 10:53 PM EDT. Investing $1,000 in blue-chip stocks can yield significant long-term returns. Two standout picks on the Toronto Stock Exchange (TSX) are Suncor Energy Inc. and Canadian National Railway Co. Suncor, a $99.8 billion energy giant, benefits from rising crude prices and an integrated business model spanning extraction to retail. Its reduced costs and strong balance sheet support dividends and growth prospects. Meanwhile, Canadian National Railway, worth $85.4 billion, offers stability through its vast rail network connecting Canada and the U.S. Its steady dividends, currently yielding 2.6%, and consistent payout growth make it ideal for conservative investors. Both stocks present unique advantages amid market volatility and economic uncertainties, making them compelling additions to a self-directed portfolio.
Go toTop